Williamson Robert F III's Form 4 filing
Perspective Therapeutics, Inc. (CATX) · filed Feb 1, 2024
- Accession no.
- 0001437749-24-002837
- Filed
- Feb 1, 2024
- Trade date
- Jan 30, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market purchases total $90.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Williamson Robert F IIICIK 0001397331 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +18,579 | $0.71 | +$13,191.09 | 230,134 | Direct | |
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +5,127 | $0.71 | +$3,640.17 | 235,261 | Direct | |
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +57,121 | $0.71 | +$40,555.91 | 292,382 | Direct | |
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +42,879 | $0.72 | +$30,872.88 | 335,261 | Direct | |
| Jan 30, 2024 | Common Stock | PPurchaseAcquired | +3,500 | $0.70 | +$2,450 | 338,761 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.